Breast Cancer Survival Higher in Runners vs. Walkers

Share this content:
ACS Guideline Adherence Lowers Women's Cancer Risk
ACS Guideline Adherence Lowers Women's Cancer Risk

(HealthDay News) — For breast cancer survivors, post-diagnosis running is associated with reduced mortality versus walking, according to a study published online Jan. 27 in the International Journal of Cancer.

Paul T. Williams, PhD, from the Lawrence Berkeley National Laboratory in California, examined whether post-diagnosis running and walking differ in their impact on breast cancer mortality. Mortality was compared with baseline exercise energy expenditure (metabolic equivalents [METs], with 1 MET-hour equivalent to 1 km run) in 272 runners and 714 walkers previously diagnosed with breast cancer (mean, 7.9 years before baseline).

RELATED: Breast Cancer Resource Center

During 9.1 years of surveillance, 46 women died from breast cancer (13 runners and 33 walkers). The researchers found that breast cancer mortality decreased an average of 23.9% MET-hours/day (P = 0.004) for all runners and walkers combined. The decrease was significantly greater for running than walking (risk per MET-hours/day run vs. walked, P = 0.03). 

For the runners, there was an average decrease in breast cancer mortality of 40.9% per MET-hours/day run (P = 0.0004). Compared with less than 1.07 MET-hours/day run, breast cancer mortality was 87.4% lower for 1.8 to 3.6 MET-hours/day (P = 0.008) and 95.4% lower for the ≥3.6 MET-hours/day (P = 0.0004). For the 714 walkers, there was a nonsignificant 4.6% decrease seen in breast cancer mortality per MET-hours/day walked (P = 0.71).

RELATED: EBCC: Long-Running Screening Program Cuts Breast Cancer Deaths

"In conclusion, we have shown that breast cancer mortality in post-diagnosis runners may be lower than that of post-diagnosis walkers, and that exceeding the public health recommendation for physical activity was better than merely achieving it," Williams wrote.

References

  1. Williams PT. Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking. Int J Cancer. 2014;doi:10.1002/ijc.28740.

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs